Hanmi Science Co., Ltd.
KSC: 008930.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Jong-Hoon Lim
- Employees
- 443
- Headquarters
- Seoul, South Korea
- IPO year
- 2005
- Market cap
- ₩2.5T
- Website
- https://www.hanmiscience.co.kr
Loading 008930…
Loading profile data…Frequently asked questions about 008930
What does Hanmi Science Co., Ltd. (008930.KS) do?
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services. In addition, it operates a...
Where does 008930.KS trade?
Hanmi Science Co., Ltd. (008930.KS) trades on the Korea Exchange.
What sector is 008930.KS in?
Hanmi Science Co., Ltd. (008930.KS) operates in the Healthcare sector, specifically in the Medical - Distribution industry.
Who is the CEO of Hanmi Science Co., Ltd.?
Jong-Hoon Lim is the chief executive officer of Hanmi Science Co., Ltd. (008930.KS).
Where is Hanmi Science Co., Ltd. headquartered?
Hanmi Science Co., Ltd. is headquartered in South Korea.
Does 008930.KS pay a dividend?
Yes — Hanmi Science Co., Ltd. (008930.KS) paid a trailing twelve-month dividend of KRW 400.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 008930.KS go public?
Hanmi Science Co., Ltd. (008930.KS) completed its initial public offering in 2005.